Last reviewed · How we verify
C1 Esterase Inhibitor Injection [Cinryze]
C1 esterase inhibitor, a plasma protein that regulates the complement system
C1 esterase inhibitor, a plasma protein that regulates the complement system Used for Hereditary angioedema.
At a glance
| Generic name | C1 Esterase Inhibitor Injection [Cinryze] |
|---|---|
| Also known as | Cinryze |
| Sponsor | Haaglanden Medical Centre |
| Drug class | Complement inhibitor |
| Target | C1 esterase inhibitor |
| Modality | Small molecule |
| Therapeutic area | Immunology |
| Phase | Phase 2 |
Mechanism of action
C1 esterase inhibitor is a plasma protein that regulates the complement system by inhibiting the C1 complex, thereby preventing excessive activation of the complement cascade.
Approved indications
- Hereditary angioedema
Common side effects
- Injection site reaction
- Headache
- Nausea
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: